Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa
Ketty Peris, Ada Lo Schiavo, Gabriella Fabbrocini, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 33, Iss. 4, pp. 766-773
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life
Tien V. Nguyen, Giovanni Damiani, Lauren A.V. Orenstein, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 35, Iss. 1, pp. 50-61
Closed Access | Times Cited: 272
S2k guideline for the treatment of hidradenitis suppurativa / acne inversa – Short version
Christos C. Zouboulis, Falk G. Bechara, Klaus Fritz, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 6, pp. 868-889
Closed Access | Times Cited: 21
Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes
Alexa B. Kimball, Joslyn S. Kirby, J.R. Ingram, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 1, pp. 83-98
Open Access | Times Cited: 17
A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa
Schapoor Hessam, Lisa Scholl, Michael Sand, et al.
JAMA Dermatology (2018) Vol. 154, Iss. 3, pp. 330-330
Open Access | Times Cited: 70
Skin and Psychosomatics – Psychodermatology today
Uwe Gieler, Tanja Gieler, Eva M.J. Peters, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2020) Vol. 18, Iss. 11, pp. 1280-1298
Open Access | Times Cited: 68
S2k-Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa (ICD-10-Code: L73.2)
Christos C. Zouboulis, Falk G. Bechara, Klaus Fritz, et al.
Aktuelle Dermatologie (2024) Vol. 50, Iss. 01/02, pp. 30-83
Closed Access | Times Cited: 8
Validity of EQ‐5D‐5L, Skindex‐16, DLQI and DLQI‐R in patients with hidradenitis suppurativa
L Gergely, Krisztián Gáspár, Valentin Brodszky, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 11, pp. 2584-2592
Open Access | Times Cited: 36
A comparative study on the measurement properties of Dermatology Life Quality Index (DLQI), DLQI‐Relevant and Skindex‐16*
Ákos Szabó, Valentin Brodszky, Fanni Rencz
British Journal of Dermatology (2021) Vol. 186, Iss. 3, pp. 485-495
Open Access | Times Cited: 31
Secukinumab (Cosentyx)
CDA-AMC
Canadian Journal of Health Technologies (2025) Vol. 5, Iss. 1
Closed Access
SCI-QOL and WOUND-Q Have the Best Patient-reported Outcome Measure Design: A Systematic Literature Review of PROMs Used in Chronic Wounds
Tert C. van Alphen, Floor ter Brugge, Emiel L. W. G. van Haren, et al.
Plastic & Reconstructive Surgery Global Open (2023) Vol. 11, Iss. 1, pp. e4723-e4723
Open Access | Times Cited: 10
How to integrate surgery and targeted therapy with biologics for the treatment of hidradenitis suppurativa: Delphi consensus statements from an Italian expert panel
Annamaria Offidani, Angelo Valerio Marzano, Ketty Peris, et al.
Dermatology (2024), pp. 1-12
Open Access | Times Cited: 3
Neoplastic Implications in Patients Suffering from Hidradenitis Suppurativa under Systemic Treatments
Federica Li Pomi, Laura Macca, Alfonso Motolese, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1594-1594
Open Access | Times Cited: 17
Supporting employers and their employees with mental hEalth conditions to remain eNgaged and producTive at wORk (MENTOR): A feasibility randomised controlled trial
Arianna Prudenzi, Kiranpreet Gill, Michael R. MacArthur, et al.
Journal of Contextual Behavioral Science (2024), pp. 100720-100720
Open Access | Times Cited: 2
The impact of hidradenitis suppurativa on work productivity and activity impairment
Vijay K. Sandhu, Monica Shah, Vincent Piguet, et al.
British Journal of Dermatology (2019) Vol. 182, Iss. 5, pp. 1288-1290
Closed Access | Times Cited: 16
Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease
Gabriella Fabbrocini, Giulia Ruina, Giulia Giovanardi, et al.
Dermatology (2021) Vol. 238, Iss. 3, pp. 487-497
Open Access | Times Cited: 14
Creation of a severity index for hidradenitis suppurativa that includes a validated quality‐of‐life measure: the HIDRAscore
Angelo Valerio Marzano, Andrea Chiricozzi, G. Giovanardi, et al.
Journal of the European Academy of Dermatology and Venereology (2020) Vol. 34, Iss. 8, pp. 1815-1821
Open Access | Times Cited: 14
Quality of life in Hidradenitis Suppurativa (Acne Inversa): A scoping review
Amrit Preet Kaur, Mary Laing, Laoise Griffin, et al.
Skin Health and Disease (2023) Vol. 3, Iss. 4
Open Access | Times Cited: 4
The impact of hidradenitis suppurativa on work productivity and performance: a systematic review and meta-analysis
Serena Altaf Merchant, Syed Fazal Hussein Shah
Clinical and Experimental Dermatology (2024) Vol. 49, Iss. 10, pp. 1156-1163
Closed Access | Times Cited: 1
The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality‐of‐life instruments: A systematic review
Jui Vyas, Jeffrey Johns, Yasmina Abdelrazik, et al.
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access | Times Cited: 1
Age and gender influence on HIDRAdisk outcomes in adalimumab‐treated hidradenitis suppurativa patients
Gabriella Fabbrocini, Claudio Marasca, Matteo Megna, et al.
Journal of the European Academy of Dermatology and Venereology (2019) Vol. 33, Iss. S6, pp. 25-27
Open Access | Times Cited: 9
Assessing unmet needs in patients with hidradenitis suppurativa
Simran Chadha, Molly Stout, Parul Kathuria Goyal, et al.
Archives of Dermatological Research (2023) Vol. 315, Iss. 9, pp. 2555-2560
Open Access | Times Cited: 3
Haut und Psychosomatik – Psychodermatologie heute
Uwe Gieler, Tanja Gieler, Eva M.J. Peters, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2020) Vol. 18, Iss. 11, pp. 1280-1300
Open Access | Times Cited: 7
Trends in Hidradenitis Suppurativa Disease Severity and Quality of Life Outcome Measures: Scoping Review
Jalal Maghfour, Torunn E Sivesind, Robert P. Dellavalle, et al.
JMIR Dermatology (2021) Vol. 4, Iss. 2, pp. e27869-e27869
Open Access | Times Cited: 7
Supporting employers and their employees with Mental hEalth problems to remain eNgaged and producTive at wORk (MENTOR): A feasibility randomised controlled trial protocol
Arianna Prudenzi, Ferozkhan Jadhakhan, Kiranpreet Gill, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0283598-e0283598
Open Access | Times Cited: 2
S2k‐Leitlinie zur Therapie der Hidradenitis suppurativa/Acne inversa – Kurzfassung
Christos C. Zouboulis, Falk G. Bechara, Klaus Fritz, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 6, pp. 868-892
Closed Access
Page 1 - Next Page

Scroll to top